↓ Skip to main content

American Association for Cancer Research

Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning

Overview of attention for article published in Cancer Discovery, September 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
twitter
6 X users
patent
3 patents
facebook
1 Facebook page
video
1 YouTube creator

Citations

dimensions_citation
428 Dimensions

Readers on

mendeley
279 Mendeley
citeulike
1 CiteULike
Title
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Published in
Cancer Discovery, September 2012
DOI 10.1158/2159-8290.cd-12-0263
Pubmed ID
Authors

Michael N Pollak

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 279 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
Netherlands 2 <1%
Canada 2 <1%
Japan 2 <1%
United Kingdom 1 <1%
Brazil 1 <1%
Unknown 268 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 53 19%
Researcher 36 13%
Student > Master 36 13%
Student > Bachelor 35 13%
Student > Doctoral Student 19 7%
Other 58 21%
Unknown 42 15%
Readers by discipline Count As %
Medicine and Dentistry 72 26%
Biochemistry, Genetics and Molecular Biology 55 20%
Agricultural and Biological Sciences 48 17%
Pharmacology, Toxicology and Pharmaceutical Science 18 6%
Chemistry 11 4%
Other 23 8%
Unknown 52 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2024.
All research outputs
#1,733,465
of 25,837,817 outputs
Outputs from Cancer Discovery
#831
of 4,151 outputs
Outputs of similar age
#10,846
of 191,456 outputs
Outputs of similar age from Cancer Discovery
#2
of 44 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,151 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.2. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,456 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.